Guo-jun Hou
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Circular RNA cFAM210A, degradable by HBx, inhibits HCC tumorigenesis by suppressing YBX1 transactivation.
Journal: Experimental & molecular medicine
Published: January 12, 2023
Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma.
Journal: British journal of cancer
Published: July 14, 2022
IL-17A promotes the invasion-metastasis cascade via the AKT pathway in hepatocellular carcinoma.
Journal: Molecular oncology
Published: October 16, 2017
Distinct role of nuclear receptor corepressor 1 regulated de novo fatty acids synthesis in liver regeneration and hepatocarcinogenesis in mice.
Journal: Hepatology (Baltimore, Md.)
Published: May 08, 2017
Erratum: Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma.
Journal: Nature communications
Published: November 09, 2016
Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma.
Journal: Nature communications
Published: January 29, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026